Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcomaMing‐Rui Du, Jixian Qian, Cheng-Pei Zhou et al.|Journal of Experimental & Clinical Cancer Research|2022Cited by 28
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancerChenlin Liu, Yuan Gao|Journal of Nanobiotechnology|2025Cited by 10
Additional file 1 of Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcomaMing‐Rui Du, Jixian Qian, Chenlin Liu et al.|Open MIND|2022Cited by 0